newsfilter
← Latest News
GlobeNewswire·

Selecta Biosciences to Participate at the SVB Securities Global Biopharma Conference

WATERTOWN, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies for